- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.50 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 3 residues within 4Å:- Chain A: Y.28, N.61
- Chain F: L.55
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: N.122, T.124, N.125
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: T.108, N.234
Ligand excluded by PLIPNAG.11: 4 residues within 4Å:- Chain A: N.282
- Chain C: K.558
- Chain G: G.30, G.69
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: F.338, F.342, N.343
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: E.309, N.603
Ligand excluded by PLIPNAG.14: 1 residues within 4Å:- Chain A: N.706
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.798, S.800
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: N.1095, T.1097, F.1100
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain B: N.122, A.123, N.125
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain B: E.132, N.165, T.167
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain B: N.331
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: N.706, G.1128
- Chain C: D.793
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: N.798, S.800
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain B: N.1131
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: K.462
- Chain C: N.234
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain C: N.343
Ligand excluded by PLIPNAG.30: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain C: N.706
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.798
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain C: N.1131
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, Z. et al., Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins. Immunity (2022)
- Release Date
- 2022-04-27
- Peptides
- Spike glycoprotein: ABC
C1717 Fab Heavy Chain: DFH
C1717 Fab Light Chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
DH
FE
LG
EI
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.50 Å
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, Z. et al., Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins. Immunity (2022)
- Release Date
- 2022-04-27
- Peptides
- Spike glycoprotein: ABC
C1717 Fab Heavy Chain: DFH
C1717 Fab Light Chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
DH
FE
LG
EI
G